Divi's Laboratories share price
You have to be logged in to add this to Watchlist.- ₹6,180.45(-0.13%)February 13, 2026 15:29:45 PM IST
- NSE
- BSE
- Vol : 307.02 K (NSE + BSE)Last 20 day avg : 455.93 K
Divi's Laboratories is trading -0.13% lower at Rs 6,180.45 as compared to its last closing price. Divi's Laboratories has been trading in the price range of 6,199.05 & 6,062.20. Divi's Laboratories has given -3.25% in this year & 0.71% in the last 5 days. There are 27 analysts who have initiated coverage on Divi's Laboratories. There are 5 analysts who have given it a strong buy rating & 7 analysts have given it a buy rating. 6 analysts have given the stock a sell rating.The company posted a net profit of 583.00 Crores in its last quarter.Listed peers of Divi's Laboratories include Dr Reddy's Laboratories (-0.51%), Torrent Pharmaceuticals (-0.18%), Cipla (0.16%).The Mutual Fund holding in Divi's Laboratories was at 13.73% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Divi's Laboratories was at 20.08% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 15, 2026, 02:28 AM UTC
- BetaLow volatility0.71Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Dividend YieldLower than industry0.49Annual dividends as a percentage of the stock price.
- P/BHigher than historical values10.97The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values66.19Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-6.93The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr Reddy's Laboratories | Bullish | 1,268.00 | -0.51 | 1,05,788.83 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,074.05 | -0.18 | 1,37,562.02 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,331.70 | 0.16 | 1,07,570.97 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Neutral | 1,698.00 | -0.97 | 4,07,849.42 | 36.24 | 5.77 | 0.92 | 0.50 |
| Lupin | Bullish | 2,199.20 | -0.50 | 1,00,496.40 | 28.78 | 5.59 | 0.57 | 11.80 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-17 | Audited Results & Dividend |
| 2025-02-03 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE361B01024
- BSE Code532488
- NSE CodeDIVISLAB
Divi's Laboratories is trading at 6180.45 as on Fri Feb 13 2026 09:59:45. This is -0.13% lower as compared to its previous closing price of 6188.20.
The market capitalization of Divi's Laboratories is 164071.53 Cr as on Fri Feb 13 2026 09:59:45.
The average broker rating on Divi's Laboratories is Hold. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 7 analysts have given a buy rating
- 5 analysts have given a hold rating
- 6 analysts have given a sell rating
- 4 analysts have given a strong sell rating
The 52 wk high for Divi's Laboratories is 7077.70 whereas the 52 wk low is 4941.70
Divi's Laboratories can be analyzed on the following key metrics -
- TTM P/E: 68.41
- Sector P/E: -
- Dividend Yield: 0.49%
- D/E ratio: -
Divi's Laboratories reported a net profit of 2191.00 Cr in 2025.
The Mutual Fund Shareholding was 13.73% at the end of 31 Dec 2025.